Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
FTI-276 is a CAAX peptidomimetic inhibitor of farnesyltransferase (FTase; IC50 = 500 pM).1 It contains the C-terminal CAAX sequence, Cys-Val-Iso-Met (CVIM), of K-Ras4B, a form of Ras that is commonly mutated in human cancers, and is selective for FTase over geranylgeranyltransferase I (GGTase I; IC50 = 50 nM). It inhibits the growth of NIH3T3 cells expressing oncogenic farnesylated H-Ras (RasF), but not geranylgeranylated H-Ras (RasGG) or Raf, when used at a concentration of 20 µM.2 FTI-276 (50 mg/kg) also reduces tumor growth in a mouse xenograft model using Calu-1 cells that contain a K-Ras oncogenic mutation but not in a model using NCI H810 cells that do not contain a K-Ras mutation.
WARNING This product is not for human or veterinary use.
1. Ras CAAX peptidomimetic FTI-
2. Ras CAAX peptidomimetic FTI 276 selectively blocks tumor growth in nude mice of a human lung carcinoma with K-